Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia-Reference-Cited by-同舟云学术

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

Published:2001 Issue:5 Volume:49 Page:590-596
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Lodi Raffaele,Hart Paul E.,Rajagopalan Bheeshma,Taylor Doris J.,Crilley Jenifer G.,Bradley Jane L.,Blamire Andrew M.,Manners David,Styles Peter,Schapira Anthony H.V.,Cooper J. Mark

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference30 articles.

1. FRIEDREICH'S ATAXIA: A CLINICAL AND GENETIC STUDY OF 90 FAMILIES WITH AN ANALYSIS OF EARLY DIAGNOSTIC CRITERIA AND INTRAFAMILIAL CLUSTERING OF CLINICAL FEATURES

2. Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia

3. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

4. Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes

5. Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases;Biomedicine & Pharmacotherapy;2024-06

2. Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology;Ageing Research Reviews;2024-04

3. Bridging the gap: R-loop mediated genomic instability and its implications in neurological diseases;Epigenomics;2024-03-26

4. Neuroprotective potential of coenzyme Q10;Natural Molecules in Neuroprotection and Neurotoxicity;2024

5. Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle;Experimental Physiology;2023-12-14